Maria-jesus J. Sanz
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Tirzepatide, a dual GIP/GLP-1 receptor agonist, attenuates endothelial dysfunction and angiotensin II-induced abdominal aortic aneurysm in ApoE-/- mice.
Journal: Pharmacological research
Published: February 13, 2026
Key role of activated platelets in the enhanced adhesion of circulating leucocyte-platelet aggregates to the dysfunctional endothelium in early-stage COPD.
Journal: Frontiers in immunology
Published: May 31, 2024
Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?
Journal: Pharmacological research
Published: July 26, 2023
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.
Journal: International journal of molecular sciences
Published: December 23, 2022
Anti-inflammatory effects and improved metabolic derangements in ob/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity.
Journal: Pharmacological research
Published: November 14, 2022
Synthesis and biological studies of "Polycerasoidol" and "trans-δ-Tocotrienolic acid" derivatives as PPARα and/or PPARγ agonists.
Journal: Bioorganic & medicinal chemistry
Published: September 29, 2021
Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 13, 2021
Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity.
Journal: Microvascular research
Published: February 02, 2021
Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients.
Journal: Frontiers in pharmacology
Published: January 20, 2021
Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction.
Journal: The international journal of biochemistry & cell biology
Published: October 21, 2020
Last Updated: 09/26/2026